Details of the Drug Formulations

General Information of Drug (ID: DM1P6FR)

• Drug Name: ARRY-162 Drug Info
• Synonyms: 606143-89-9; Binimetinib; MEK162; MEK-162; ARRY-438162; 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide; ARRY 162; UNII-181R97MR71; Binimetinib (MEK162, ARRY-162, ARRY-438162); 181R97MR71; MEK162 (ARRY-162, ARRY-438162); 6-(4-bromo-2-fluorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide; Binimetinib [USAN:INN]; MEK 162; ARRY 438162; MEK162(Binimetinib); Binimetinib (JAN/USAN); D0C4LF; NVP-ME

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Approved	[1]

• Cross-matching ID:
  PubChem CID: 10288191
  ChEBI ID: CHEBI:145371
  CAS Number: 606143-89-9
  TTD ID: D0C4LF
  VARIDT ID: DR01336
  INTEDE ID: DR0214
  ACDINA ID: D00883

Full List of Drug Formulations Containing This Drug

Binimetinib 15 mg tablet

Company	Formulation ID	FDA Description
Array Biopharma	F23088	Lactose Monohydrate; Microcrystalline Cellulose; Croscarmellose Sodium; Magnesium Stearate (Vegetable Source); Colloidal Silicon Dioxide; Polyvinyl Alcohol; Polyethylene Glycol; Titanium Dioxide; Talc; Ferric Oxide Yellow; Ferrosoferric Oxide

References

• [1] 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.